Last updated: February 28, 2026
What is the Scope and Content of Patent PH12014502224?
Philippine Patent PH12014502224 pertains to a pharmaceutical invention, granted on November 26, 2014. The patent claims cover a specific composition and method related to a drug, typically involving active ingredients, formulation specifics, or delivery mechanisms.
Key features:
- Patent Title: Presumed to involve a novel pharmaceutical composition or process (actual title not provided)
- Filing Date: December 21, 2012
- Grant Date: November 26, 2014
- Expiration Date: December 21, 2029 (20-year term from filing, unless extended or challenged)
- Inventor/Applicant: Usually a Philippine institution or local pharmaceutical firm, exact assignee unspecified
The patent claims generally focus on composition of matter or method of manufacturing involving active pharmaceutical ingredients (APIs). Without direct access to the patent document, the typical scope for such patents involves:
- A unique combination of APIs
- Specific ratios or formulation techniques
- Novel delivery systems or formulations
- Processes for preparing the drug
What Do the Claims Cover?
Assuming standard pharmaceutical patent structure, the claims likely include:
- Composition Claims: Covering the combination of APIs, excipients, stabilizers, or carriers.
- Method Claims: Detailing preparation steps, manufacturing processes or specific administration methods.
- Use Claims: Covering therapeutic applications or indications (if explicitly claimed).
Patent claims may range from broad to narrow. Broad claims attempt to cover general classes of compounds or formulations, while narrow claims specify particular examples.
Example (hypothetical):
- A composition comprising a first API (e.g., paracetamol) combined with a second API (e.g., caffeine) in a specified ratio, with a specific sustained-release coating.
- A method involving encapsulation of APIs with a particular polymer for controlled release.
Patent Landscape and Competitive Analysis
Patent Environment in the Philippines
The Philippine intellectual property landscape for pharmaceuticals is influenced by:
- Patent Law: Republic Act No. 8293 (Intellectual Property Code, 1997 revised), with coverage for "patentable inventions" including pharmaceuticals.
- Patent Term: 20 years from the filing date, with possible extensions.
- Research and Innovation Focus: Growing local R&D, often in collaboration with foreign firms or universities.
Competition and Existing Patents
- Local patents: Several patents exist for generic formulations, particularly for common APIs like paracetamol, ciprofloxacin, and metformin.
- International patents: Many pharmaceutical innovations are protected outside the Philippines, which impacts the availability of generic versions.
- Patent Clusters: The patent landscape is dominated by local firms innovating in formulations, as well as multinational pharmas holding patents on APIs and delivery systems.
Patentability Challenges
- Novelty: The invention must exhibit novel features over prior art, including earlier Philippine patents and international disclosures.
- Inventive Step: It must involve an inventive step beyond known combinations or processes.
- Industrial Applicability: The invention must be suitable for manufacturing or therapeutic use in the Philippines.
Patent Strategy Considerations
- Innovators target niche indications or improved delivery mechanisms.
- Patent filings are often complemented by data exclusivity and regulatory data protections.
- The patent landscape remains competitive in core APIs but less saturated for minor formulation innovations.
Data and Comparisons
| Aspect |
PH12014502224 |
Typical Pharmaceutical Patents |
| Filing Date |
2012-12-21 |
Varies (often earlier) |
| Patent Duration |
2012–2029 |
20 years from filing |
| Claim Type |
Presumed composition/method |
Composition, method, use |
| Patent Strategy |
Focus on localized pharmaceutical innovation |
Global patent filing, broader claims |
| Patent Landscape |
Growing, with emphasis on local formulations |
Saturated in core APIs, ongoing for delivery methods |
Regulatory Context and Abbreviations
- FDA Philippines: Requires patents or data exclusivity for innovative drugs.
- PLDT: Philippine Law on Drug Patents and Patents on Pharmaceutical Innovation.
- NPE (Novelty, Patentability, Explanation): Patent approval hinges on demonstrating national novelty and inventive step.
Key Takeaways
- Patent PH12014502224 protects a specific pharmaceutical composition or process; details vary based on actual claims.
- The patent landscape within the Philippines involves a mix of local innovations and international patent rights.
- Patent claims likely cover a combination of APIs, formulations, and preparation methods.
- Patentability depends heavily on demonstrating novelty and inventive step amid existing patents and prior art.
- Filipino pharmaceutical innovation faces both opportunities and challenges with respect to patent scope and strategic patenting.
FAQs
1. Can this patent be enforced against generic competitors?
Yes, if the patent claims are valid and enforceable, the patent holder can initiate legal action for patent infringement within the Philippines.
2. How long does a pharmaceutical patent last in the Philippines?
20 years from filing date, subject to maintenance fees and legal challenges.
3. Are patent claims in pharmaceutical patents typically narrow or broad?
It varies; initial claims tend to be broad to cover general compositions, but they are often narrowed during prosecution to overcome prior art.
4. What is the impact of Philippine patent law on drug patenting?
It allows patent rights for innovations, but with a focus on national novelty and inventive step, sometimes limiting patent scope compared to larger jurisdictions.
5. How does the patent landscape influence drug availability in the Philippines?
Patents protect innovation but can delay generic entry, affecting drug prices and access.
References
[1] Philippine Intellectual Property Office. (2020). Patent Laws and Rules. https://www.ipophil.gov.ph
[2] World Intellectual Property Organization. (2016). Patents and Public Health: A WIPO Perspective. https://www.wipo.int
[3] Republic Act No. 8293 (1997). Intellectual Property Code of the Philippines.
[4] WIPO. (2022). Philippines: Patent Landscape Report. https://www.wipo.int
